Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone

被引：0
|
作者：
Oliver Kummer
Felix Hammann
Claudine Moser
Olivier Schaller
Jürgen Drewe
Stephan Krähenbühl
机构：
[1] University Hospital,Division of Clinical Pharmacology and Toxicology, Department of Biomedicine
[2] Mundipharma Medical Company,undefined
来源：
European Journal of Clinical Pharmacology | 2011年 / 67卷
关键词：
Oxycodone; Ketoconazole; Paroxetine; Drug interactions; Pharmacokinetics; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：63 / 71
页数：8
相关论文
共 50 条
  • [41] Sugar-mediated lyoprotection of purified human CYP3A4 and CYP2D6
    Chefson, Amandine
    Zhao, Jin
    Auclair, Karine
    JOURNAL OF BIOTECHNOLOGY, 2007, 130 (04) : 436 - 440
  • [42] Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol
    Kirchheiner, Julia
    Keulen, Jan-Tobias H. A.
    Bauer, Steffen
    Roots, Ivar
    Brockmoeller, Juerge
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) : 78 - 83
  • [43] Impact of CYP2D6 Genetic Polymorphism on Tramadol Pharmacokinetics and Pharmacodynamics
    Siew Hua Gan
    Rush Ismail
    Wan Aasim Wan Adnan
    Wan Zulmi
    Molecular Diagnosis & Therapy, 2007, 11 (3) : 171 - 181
  • [44] Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics
    Sehrt, Daniel
    Meineke, Ingolf
    Tzvetkov, Mladen
    Gueltepe, Senol
    Brockmoeller, Jurgen
    PHARMACOGENOMICS, 2011, 12 (06) : 783 - 795
  • [45] Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions
    LLerena, Adrian
    Dorado, Pedro
    Penas-LLedo, Eva M.
    PHARMACOGENOMICS, 2011, 12 (03) : 311 - 311
  • [46] Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics
    Gan, Siew Hua
    Ismail, Rusli
    Adnan, Wan Aasim Wan
    Zulmi, Wan
    MOLECULAR DIAGNOSIS & THERAPY, 2007, 11 (03) : 171 - 181
  • [47] Influence of CYP2D6 phenotype on the Pharmacokinetics-Pharmacodynamics of tramadol
    Percevault, S.
    De La Gastine, B.
    Varin, L.
    Richard, N.
    Loilier, M.
    Bleyzac, N.
    Bourguignon, L.
    Lelong-Boulouard, V.
    Goutelle, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 43 - 44
  • [48] CYP2D6 genotype and risperidone pharmacokinetics, pharmacodynamics and side effects
    Novalbos, J.
    Lopez-Rodriguez, R.
    Roman, M.
    PHARMACOGENOMICS, 2011, 12 (03) : 312 - 312
  • [49] Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers
    Belmonte, Carmen
    Ochoa, Dolores
    Roman, Manuel
    Saiz-Rodriguez, Miriam
    Wojnicz, Aneta
    Isabel Gomez-Sanchez, Clara
    Martin-Vilchez, Samuel
    Abad-Santos, Francisco
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (06) : 596 - 605
  • [50] A meta-analysis of the effect of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamics of metoprolol
    Li, Shuchun
    Lin, Han
    Sun, WenHuan
    Wang, YingLi
    Ding, YouFang
    Zhao, HuanHu
    Liu, ShangJian
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (06) : 483 - 492
12345